Erectile Dysfunction Drugs Market which is Expected to reach USD 10.2 billion by 2035

Pune, India, July 2023 /MRFR Press Release/- Market research future has a half cooked research report on Global erectile dysfunction drugs Market. The global market for erectile dysfunction drugs is growing continuously and expected to grow at a CAGR of 6.5% from 2024 to 2035

Global Erectile Dysfunction Drugs Market Report Highlights

Global Erectile dysfunction drugs market is expected to reach USD 10.2 billion by 2035 at a CAGR of 4.43% during forecast period 2024 to 2035.

Erectile dysfunction is the inability to maintain sufficient for satisfactory sexual performance. Management of this disorder includes medical history, sexual history and psychological history of a person. There are number of drugs available for the treatment of erectile dysfunction which include both branded and generic drugs. Changing lifestyle and increase in lifestyle disorders, availability of wide range of drugs for the treatment of erectile. 

Test the market data and market information presented through more than 45 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Erectile dysfunction drugs market Research Report –Global Forecast to 2030.”

Global erectile dysfunction drugs market Players:

Key players in erectile dysfunction drugs market are: Pfizer Inc. (U.S), Bayer AG (Germany), Eli Lily & Co. (U.S), Dong–A Pharmaceutical Co. Ltd. (South Korea), Apricus Biosciences Inc. (U.S), S.K. Chemicals Co. Ltd. (South Korea), Apricus Biosciences Inc. (U.S).

Pfizer Inc. is an American global pharmaceutical corporation headquartered in New York City.  It is among the world's largest pharmaceutical companies. Pfizer develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, diabetology/endocrinology, and neurology. Viagra drug for erectile dysfunction treatment manufactured by the company. In June 1, 2017, Pfizer Limited (India) acquired AstraZeneca’s Neksium.

Bayer AG is a chemical, pharmaceutical and life science company. It is one of the major players manufacturing drugs for erectile dysfunction. Levitra is a product offered by the company for this disorder. It is a major competitor for Pfizer in this market.

Eli Lilly and Company is an American global pharmaceutical company with headquarters located in Indianapolis, Indiana, in the United States. The company also has offices in Puerto Rico and 17 other countries. Its products are sold in approximately 125 countries. The company manufactures a drug named Cialis for erectile dysfunction. In January, 2017, the Eli Lilly Company was awarded as world’s most ethical company.

Figure 1          Major players in the Global erectile dysfunction drugs market, 2016

Segmentation:Figure 2          Global erectile dysfunction drugs market, by product, 2016 (%) 

Global Erectile dysfunction drugs market has been segmented on the basis of product which includes Viagra, Cialis, Levitra, Stendra, Zydena and other drugs and on the basis of end users the market is segmented into Hospitals, clinics, pharmaceutical companies and others.